Hepatotoxicity of Herbal Preparations

Zakim and Boyer's Hepatology

Volumn , Issue , 2012, Pages 462-475

  Strader, Doris B ^a   Navarro, Victor J ^b   Seeff, Leonard B ^c  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870596718     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0881-3.00026-7     Document Type: Chapter

References (272)

1. Adachi M, et al. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med 2003, 139:488-492. (Ref.163).
2. Bjornsson E, Olsson R Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol 2007, 47:295-297. (Ref.109).
3. Bonkovsky HL Hepatotoxicity associated with supplements containing Chinese green teas (Camellia sinensis). Ann Intern Med 2006, 144:68-69. (Ref.106).
4. Borrelli F, Ernst E Black cohosh (Cimicifuga racemosa). A systematic review of adverse events. Am J Obstet Gynecol 2008, 199:455-466. (Ref.53).
5. Borum ML Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001, 96:1654-1655. (Ref.142).
6. Bressler R Herb-drug interactions: interactions between kava and prescription medications. Geriatrics 2005, 60:24-25. (Ref.139).
7. Centers for Disease Control and Prevention (CDC) Hepatic toxicity possibly associated with kava-containing products-United States, Germany and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep 2002, 51(47):1065-1067. (Ref.131).
8. Chitturi S, Farrell GC Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000, 15:1093-1099. (Ref.35).
9. Chow EC, et al. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008, 188:420-422. (Ref.47).
10. Cohen DL, Del Toto Y A case of valerian-associated hepatotoxicity. J Clin Gastroenterol 2008, 42:961-962. (Ref.161).
11. Cohen SM, et al. Autoimmune hepatitis associated with the use herbal preparations containing black cohosh. Menopause 2004, 11:575-577. (Ref.48).
12. Conti E, et al. Lycopodium similiaplex-induced acute hepatitis: a case report. Eur J Gastroenterol Hepatol 2008, 20:468-471. (Ref.128).
13. Dai N, et al. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol 2007, 13:1628-1631. (Ref.72).
14. Daniele C, et al. Atractylis gummifera L. poisoning-an ethnopharmacologic review. Ethnopharmacology 2005, 97. 175-162. (Ref.37).
15. Dara L, Hewett J, Lim K Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008, 14:6999-7004. (Ref.118).
16. De Berardinis V, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000, 58:542-551. (Ref.100).
17. DeLeve LD, et al. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 2003, 125:882-890. (Ref.87).
18. DeLeve LD, Shulman HM, McDonald GB Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002, 22:27-42. (Ref.36).
19. De Smet PA Herbal medicine in Europe-relaxing regulatory standards. N Engl J Med 2005, 352:1176-1178. (Ref.3).
20. Directive 2004/24/EC of the European Parliament and of the council amending, as regards traditional herbal medicinal products, Directive 2001/83 EC on the community code relating to the medicinal products for human use Official Journal of the European Union; Available at, (Ref.8). http://www.mhra.gov.uk/home/groups/es-herbal/documents/websiteresources/ con009359.pdf.
21. Dourakis SP, et al. Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur J Gastroenterol Hepatol 2002, 14:693-696. (Ref.93).
22. Duque JM, et al. Hepatotoxicity associated with the consumption of herbal slimming products. Med Clin (Barc) 2007, 128:238-239. (Ref.124).
23. Durazo FA, et al. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol 2004, 99:950-952. (Ref.169).
24. Elinav E, et al. Association between Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007, 47:514-520. (Ref.123).
25. Estes JD, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003, 138:852-858. (Ref.145).
26. European Medicines Evaluation Agency Assessments of case reports connected to herbal medicinal products containing Cimicifigae racemosae rhizome (black cohosh root) Available at, Accessed Nov 15, 2008. (Ref.51). http://www.emaeeuropa.eu/pdfs/human/hmpe/26925806.pdf.
27. Favreau JT, et al. severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 2002, 136:590-595. (Ref.168).
28. Fong T-L, et al. Hepatotoxicity due to Hydroxycut 2010; a case series. Am J Gastroenterol 2010, 105:1561-1566. (Ref.121).
29. Fu PP, et al. Toxicity of kava-kava. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008, 26:89-112. (Ref.137).
30. Fugh-Berman A Herb-drug interactions. Lancet 2000, 355:134-138. (Ref.23).
31. Galati G, et al. Cellular and in-vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 2006, 40:570-580. (Ref.112).
32. Garcia-Cortez M, et al. Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry. Span J Gastroenterol 2008, 100:688-695. (Ref.110).
33. Gardiner P, et al. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006, 166:1968-1974. (Ref.7).
34. Gloro R, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005, 17:1135-1137. (Ref.105).
35. Goodin MG, Bray BJ, Rosen RJ Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse. Food Chem Toxicol 2006, 44:1496-1504. (Ref.114).
36. Gow PJ, et al. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003, 178:442-443. (Ref.134).
37. Han D, et al. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol 2004, 67:439-451. (Ref.172).
38. Humbertson CL, Akhtar J, Krenzelok EP Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol 2003, 41:109-113. (Ref.135).
39. Jiminez-Saenz M, Martinez-Sanchez MDC Acute hepatitis associated wit the use of green tea infusions. J Hepatol 2006, 44:616-617. (Ref.107).
40. Jones FJ, Andrews AH Acute injury associated with the herbal supplement Hydroxycut in a soldier deployed in Iraq. Am J Gastroenterol 2007, 102:2357-2358. (Ref.117).
41. Jorge OA, Jorge AD Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm 2005, 97:115-124. (Ref.162).
42. Karliova M, et al. Interaction of Hypericum perforatum (St John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000, 33:853-855. (Ref.21).
43. Kauma H, et al. Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets. Scand J Gastroenterol 2004, 39:1168-1171. (Ref.66).
44. Kawaguchi T, et al. Severe hepatotoxicity associated with N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol 2004, 19:349-350. (Ref.167).
45. Laczek J, Duncan M Three cases of acute hepatitis in patients taking Hydroxycut bodybuilding supplement. Am J Gastroenterol 2008, 103(S1):143. (Ref.119).
46. Levitsky J, et al. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005, 50:538-539. (Ref.45).
47. Lopaz-Capero Andrada JM, et al. Hepatotoxicity caused by a Noni (Morinda citrifolia) preparation. Rev Esp Enferm Dig 2007, 99:179-181. (Ref.155).
48. Lynch CR, Hutson WR Fulminant hepatic failure associated with the use of black cohosh. Liver Transpl 2006, 12:989-992. (Ref.46).
49. Manso G, et al. Spanish reports of hepatotoxicity associated with Herbalife products. J Hepatol 2008, 49:289-290. (Ref.125).
50. Mazzanti G, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009, 65:331-341. (Ref.111).
51. Millonig G, Stadlmann S, Vogel W Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 2005, 17:445-447. (Ref.152).
52. Ministry of Health, Labor, and Welfare Hepatic injury in cases taking self-imported healthfoods or non-approved drugs [press release]. Ministry of Health, Labor, and Welfare Accessed at (Ref.166). http://www.mhlw.go.jp/houdou/2002/07/bo712-1.html.
53. Molinari M, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006, 12:1892-1895. (Ref.108).
54. Moro PA, et al. Hepatitis from greater celandine (Chelidonium majus L.): review of literature and report of a new case. J Ethnopharmacol 2009, 124:328-332. (Ref.101).
55. Nadir A, et al. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gostroenterol 1996, 91:1436-1438. (Ref.115).
56. Nadir A, Reddy D, Van Thiel DH Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000, 95:3634-3637. (Ref.62).
57. Nakagawa Y, et al. ATP-generating glycolytic substrates prevent N-nitrosofenfluramine-induced cytotoxicity in isolated rat hepatocytes. Chem Biol Interact 2006, 164:93-101. (Ref.165).
58. Neff GW, et al. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol 2004, 41:1062-1064. (Ref.143).
59. Pedros C, et al. Liver toxicity of Camellia sinensis dried ethanolic extract. Med Clin 2003, 121:598-599. (Ref.104).
60. Poon WT, et al. Hepatitis induced by Teucrium viscidum. Clin Toxicol 2008, 46:819-822. (Ref.94).
61. Popat A, et al. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 2001, 34:229-236. (Ref.39).
62. Popat A, et al. Mechanism of impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells. Clin Biochem 2002, 35:57-64. (Ref.40).
63. Rasenack R, et al. Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn Ther 2003, 18:223-225. (Ref.84).
64. Russmann S, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003, 15:1033-1036. (Ref.133).
65. Russmann S, Lauterburg BH, Helbling A Kava hepatotoxicity. Ann Intern Med 2001, 135:68-69. (Ref.140).
66. Sanchez W, et al. Severe hepatotoxicity associated with the use of the dietary supplement containing usnic acid. Mayo Clin Proc 2006, 81:541-544. (Ref.170).
67. Saper RB, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004, 292:2868-2873. (Ref.12).
68. Sarma DN, et al. Safety of green teas extracts: a systematic review of the US Pharmacopeia. Drug Saf 2008, 31:469-484. (Ref.102).
69. Schmidt M, et al. Toxicity of green tea extracts and their constituents in primary culture. Food Chem Toxicol 2005, 43:307-314. (Ref.113).
70. Schoepfer AM, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007, 47:521-526. (Ref.122).
71. Seeff LB, et al. Herbal product use by persons enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) Trial. Hepatology 2008, 47:605-612. (Ref.6).
72. Shim M, Saab S Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009, 54:406-408. (Ref.120).
73. Shimizu I Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 2000, 15(Suppl):D84-D90. (Ref.88).
74. Singh YN Potential for interaction of kava and St John's wort and prescription medications. J Ethnopharmacol 2005, 100:108-113. (Ref.138).
75. Skoulidid F, Alexander G, Davies SE Ma huang associated liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol 2005, 17:581-584. (Ref.144).
76. Stadlbauer V, et al. Hepatotoxicity of noni juice: report of two cases. World J Gastroenterol 2005, 11:4758-4760. (Ref.153).
77. Stadlbauer V, et al. Herbal does not mean innocuous: the sixth case of hepatotoxicity associated with Morinda citrifolia (noni). Am J Gastroenterol 2008, 103:2406-2407. (Ref.156).
78. Stedman C Herbal hepatotoxicity. Semin Liver Dis 2002, 22:195-206. (Ref.9).
79. Steenkamp V, Stewart MJ, Zuckermam M Clinical and analytic aspects of pyrrolizidine poisoning cause by South African traditional medicines. Ther Drug Monit 2000, 22:303-306. (Ref.83).
80. Stevens T, Qadri A, Zein NN Two patients with acute liver injury associated with the use of the herbal weight-loss supplement Hydroxycut. Ann Intern Med 2005, 142:477-478. (Ref.116).
81. Stewart MJ, Steenkamp V The biochemistry and toxicity of atractyloside: a review. Ther Drug Monit 2000, 22:641-649. (Ref.42).
82. Stickel F, et al. Hepatitis induced by kava (Piper methysticum rhizome). J Hepatol 2003, 39:62-67. (Ref.130).
83. Stickel F, et al. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009, 50:111-117. (Ref.15).
84. Stickel F, Egerer G, Seitz HK Hepatotoxicity of botanicals. Public Health Nutr 2000, 3:113-124. (Ref.38).
85. Strader DB, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002, 97:2391-2397. (Ref.5).
86. Teschke R, et al. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas 2009, 63:302-314. (Ref.52).
87. Teschke R, Gaus W, Loew D Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 2003, 10:440-446. (Ref.141).
88. Teschke R, Genthner A, Wolff A Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herb mixtures. J Ethnopharmacol 2009, 123:378-384. (Ref.129).
89. Teschke R, Schwarzenboeck A, Hennermann K-H Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008, 20:1182-1193. (Ref.132).
90. Thomsen M Hepatotoxicity of Cimicifuga racemosa? Recent Australian case not sufficiently substantiated. J Altern Med 2003, 9:337-340. (Ref.50).
91. Uc A, Bishop WP, Sanders KD Camphor hepatotoxicity. South Med J 2000, 93:596-598. (Ref.54).
92. Vial T, et al. Acute hepatitis due to Exolise, a Camellia sinensis-derived drug. Gastroenterol Clin Biol 2003, 27:1166-1167. (Ref.103).
93. Vitetta L, Thomsen M, Sali A Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2003, 178:411-412. (Ref.49).
94. Wang MY, et al. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002, 23:1127-1141. (Ref.150).
95. Wang X, Kanel GC, DeLeve LD Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 2000, 31:428-434. (Ref.86).
96. Weise B, et al. Toxic hepatitis after intake of kava-kava. Verdauungskrankheiten 2003, 4:166-169. (Ref.136).
97. West BJ, Jensen JJ, Westendorf J Noni juice is not hepatotoxic. World J Gastroenterol 2006, 12:3616-3619. (Ref.157).
98. Whiting PW, Clouston A, Kerlin P Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002, 177:440-443. (Ref.44).
99. Wilson KM, et al. Use of complementary medicine and dietary supplements among U.S. adolescents. J Adolesc Health 2006, 38:385-394. (Ref.2).
100. Yuce B, et al. Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?. Digestion 2006, 73:167-170. (Ref.154).
101. Eisenberg DM, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575.
102. Wilson KM, et al. Use of complementary medicine and dietary supplements among U.S. adolescents. J Adolesc Health 2006, 38:385-394.
103. De Smet PA Herbal medicine in Europe-relaxing regulatory standards. N Engl J Med 2005, 352:1176-1178.
104. Available at. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandC osmeticActFDCAct/default.htm.
105. Strader DB, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002, 97:2391-2397.
106. Seeff LB, et al. Herbal product use by persons enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) Trial. Hepatology 2008, 47:605-612.
107. Gardiner P, et al. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006, 166:1968-1974.
108. Directive 2004/24/EC of the European Parliament and of the council amending, as regards traditional herbal medicinal products, Directive 2001/83 EC on the community code relating to the medicinal products for human use Official Journal of the European Union; Available at. http://www.mhra.gov.uk/home/groups/es-herbal/documents/websiteresources/ con009359.pdf.
109. Stedman C Herbal hepatotoxicity. Semin Liver Dis 2002, 22:195-206.
110. Harper J Traditional Chinese medicine for eczema. BMJ 1994, 308:489-490.
111. Shaw D, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf 1997, 17:342-356.
112. Saper RB, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004, 292:2868-2873.
113. Kew J, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993, 306:506-507.
114. Keen RW, et al. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J 1994, 70:113-114.
115. Stickel F, et al. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009, 50:111-117.
116. Benichou C Criteria of drug-induced liver disorders. Report of an international consensus meeting. Hepatology 1990, 11:272-276.
117. Danan G, Benichou C Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993, 46:1323-1330.
118. Benichou C, Danan G, Flahault A Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993, 46:1331-1336.
119. Maria VA, Victorino RM Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997, 26:664-669.
120. Miller LG Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998, 158:2200-2211.
121. Karliova M, et al. Interaction of Hypericum perforatum (St John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000, 33:853-855.
122. Cheng TO Warfarin danshen interaction. Ann Thorac Surg 1999, 67:894.
123. Fugh-Berman A Herb-drug interactions. Lancet 2000, 355:134-138.
124. Rose KD, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990, 26:880-882.
125. Janetzky K, Morreale AP Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997, 54:692-693.
126. Homma M, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995, 47:687-692.
127. Chen MF, et al. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinol Jpn 1990, 37:331-341.
128. Kao WF, et al. Podophyllotoxin intoxication: toxic effect of Bajiaolian in herbal therapeutics. Hum Exp Toxicol 1992, 11:480-487.
129. Larrey D, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992, 117:129-132.
130. Mattei A, et al. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J Hepatol 1995, 22:597.
131. Farrell GC Drug-induced liver disease 1994, Churchill Livingstone, Edinburgh, 513-518.
132. Kamiyama T, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997, 92:703-704.
133. Benninger J, et al. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999, 117:1234-1237.
134. Larrey D, Pageaux GP Hepatotoxicity of herbal remedies and mushrooms. Semin Liver Dis 1995, 15:183-188.
135. Chitturi S, Farrell GC Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000, 15:1093-1099.
136. DeLeve LD, Shulman HM, McDonald GB Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002, 22:27-42.
137. Daniele C, et al. Atractylis gummifera L. poisoning-an ethnopharmacologic review. Ethnopharmacology 2005, 97. 175-162.
138. Stickel F, Egerer G, Seitz HK Hepatotoxicity of botanicals. Public Health Nutr 2000, 3:113-124.
139. Popat A, et al. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 2001, 34:229-236.
140. Popat A, et al. Mechanism of impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells. Clin Biochem 2002, 35:57-64.
141. Mokhobo KP Herb use and necrodegenerative hepatitis. S Afr Med J 1976, 50:1096-1099.
142. Stewart MJ, Steenkamp V The biochemistry and toxicity of atractyloside: a review. Ther Drug Monit 2000, 22:641-649.
143. Obatomi DK, et al. Toxicity of atractyloside in precision-cut rat and porcine renal and hepatic tissue slices. Toxicol Appl Pharmacol 1998, 148:35-45.
144. Whiting PW, et al. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002, 177:440-443.
145. Levitsky J, et al. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005, 50:538-539.
146. Lynch CR, Folkers ME, Hutson WR Fulminant hepatic failure associated with the use of black cohosh. Liver Transpl 2006, 12:989-992.
147. Chow EC, et al. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008, 188:420-422.
148. Cohen SM, et al. Autoimmune hepatitis associated with the use herbal preparations containing black cohosh. Menopause 2004, 11:575-577.
149. Vitetta L, Thomsen M, Sali A Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2003, 178:411-412.
150. Thomsen M Hepatotoxicity of Cimicifuga racemosa? Recent Australian case not sufficiently substantiated. J Altern Med 2003, 9:337-340.
151. European Medicines Evaluation Agency Assessments of case reports connected to herbal medicinal products containing Cimicifigae racemosae rhizome (black cohosh root) Available at, Accessed Nov 15, 2008. http://www.emaeeuropa.eu/pdfs/human/hmpe/26925806.pdf.
152. Teschke R, et al. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas 2009, 63:302-314.
153. Borrelli F, Ernst E Black cohosh (Cimicifuga racemosa). A systematic review of adverse events. Am J Obstet Gynecol 2008, 199:455-466.
154. Uc A, Bishop WP, Sanders KD Camphor hepatotoxicity. South Med J 2000, 93:596-598.
155. Jimenez JF, et al. Chronic camphor ingestion mimicking Reye's syndrome. Gastroenterology 1983, 84:394-398.
156. Antman E, et al. Camphor overdosage. Therapeutic considerations. N Y State J Med 1978, 78:896-897.
157. Skoglund RR, Ware LL, Schanberger JE Prolonged seizures due to contact and inhalation exposure to camphor. A case report. Clin Pediatr (Phila) 1977, 16:901-902.
158. Weiss J, Catalano P Camphorated oil intoxication during pregnancy. Pediatrics 1973, 52:713-714.
159. Lahoud CA, March JA, Proctor DD Campho-Phenique ingestion: an intentional overdose. South Med J 1997, 90:647-648.
160. Riggs J, et al. Camphorated oil intoxication in pregnancy; report of a case. Obstet Gynecol 1965, 25:255-258.
161. Robertson JS, Hussain M Metabolism of camphors and related compounds. Biochem J 1969, 113:57-65.
162. Nadir A, Reddy D, Van Thiel DH Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000, 95:3634-3637.
163. Beuers U, Spengler U, Pape GR Hepatitis after chronic abuse of senna. Lancet 1991, 337:372-373.
164. Tolman KG, Hammar S, Sannella JJ Possible hepatotoxicity of Doxidan. Ann Intern Med 1976, 84:290-292.
165. Sheikh NM, Philen RM, Love LA Chaparral-associated hepatotoxicity. Arch Intern Med 1997, 157:913-919.
166. Kauma H, et al. Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets. Scand J Gastroenterol 2004, 39:1168-1171.
167. Gordon DW, et al. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 1995, 273:489-490.
168. Katz M, Saibil F Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990, 12:203-206.
169. Capdevila J, et al. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys 1988, 261:257-263.
170. Smith BC, Desmond PV Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med 1993, 23:526.
171. Obermeyer WR, et al. Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 1995, 208:6-12.
172. Dai N, et al. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol 2007, 13:1628-1631.
173. Ridker PM, McDermott WV Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989, 1:657-658.
174. Bach N, Thung SN, Schaffner F Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 1989, 87:97-99.
175. Weston CF, et al. Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) 1987, 295:183.
176. Smith LW, Culvenor CC Plant sources of hepatotoxic pyrrolizidine alkaloids. J Nat Prod 1981, 44:129-152.
177. Tyler VE Herbal medicine in America. Planta Med 1987, 53:1-4.
178. Valla D, Benhamou JP Drug-induced vascular and sinusoidal lesions of the liver. Baillieres Clin Gastroenterol 1988, 2:481-500.
179. Datta DV, et al. Herbal medicines and veno-occlusive disease in India. Postgrad Med J 1978, 54:511-515.
180. Tandon BN, et al. An epidemic of veno-occlusive disease of liver in central India. Lancet 1976, 2:271-272.
181. Roulet M, et al. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J Pediatr 1988, 112:433-436.
182. Weston CFM, et al. Venoocclusive disease of the liver secondary to the ingestion of comfrey. BMJ 1987, 295:183.
183. Steenkamp V, Stewart MJ, Zuckermam M Clinical and analytic aspects of pyrrolizidine poisoning cause by South African traditional medicines. Ther Drug Monit 2000, 22:303-306.
184. Rasenack R, et al. Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn Ther 2003, 18:223-225.
185. DeLeve LD, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999, 29:1779-1791.
186. Wang X, Kanel GC, DeLeve LD Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 2000, 31:428-434.
187. DeLeve LD, et al. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 2003, 125:882-890.
188. Shimizu I Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 2000, 15(Suppl):D84-D90.
189. Itoh S, et al. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995, 40:1845-1848.
190. Johnson PJ, McFarlane IG Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
191. MacGregor FB, et al. Hepatotoxicity of herbal remedies. BMJ 1989, 299:1156-1157.
192. Castot A, Larrey D Hepatitis observed during a treatment with a drug or tea containing wild germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol Clin Biol 1992, 16:916-922.
193. Dourakis SP, et al. Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur J Gastroenterol Hepatol 2002, 14:693-696.
194. Poon WT, et al. Hepatitis induced by Teucrium viscidum. Clin Toxicol 2008, 46:819-822.
195. Kouzi SA, McMurtry RJ, Nelson SD Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse. Chem Res Toxicol 1994, 7:850-856.
196. Lekehal M, et al. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996, 24:212-218.
197. Loeper J, et al. Hepatotoxicity of germander in mice. Gastroenterology 1994, 106:464-472.
198. Feldmann G Liver apoptosis. J Hepatol 1997, 26(Suppl 2)):1-11.
199. Fau D, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997, 113:1334-1346.
200. De Berardinis V, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000, 58:542-551.
201. Moro PA, et al. Hepatitis from greater celandine (Chelidonium majus L.): review of literature and report of a new case. J Ethnopharmacol 2009, 124:328-332.
202. Sarma DN, et al. Safety of green teas extracts: a systematic review of the US Pharmacopeia. Drug Saf 2008, 31:469-484.
203. Vial T, et al. Acute hepatitis due to Exolise, a Camellia sinensis-derived drug. Gastroenterol Clin Biol 2003, 27:1166-1167.
204. Pedros C, et al. Liver toxicity of Camellia sinensis dried ethanolic extract. Med Clin 2003, 121:598-599.
205. Gloro R, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005, 17:1135-1137.
206. Bonkovsky HL Hepatotoxicity associated with supplements containing Chinese green teas (Camellia sinensis). Ann Intern Med 2006, 144:68-69.
207. Jiminez-Saenz M, Martinez-Sanchez MDC Acute hepatitis associated with the use of green tea infusions. J Hepatol 2006, 44:616-617.
208. Molinari M, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006, 12:1892-1895.
209. Bjornsson E, Olsson R Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol 2007, 47:295-297.
210. Garcia-Cortez M, et al. Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry. Span J Gastroenterol 2008, 100:688-695.
211. Mazzanti G, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009, 65:331-341.
212. Galati G, et al. Cellular and in-vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 2006, 40:570-580.
213. Schmidt M, et al. Toxicity of green tea extracts and their constituents in primary culture. Food Chem Toxicol 2005, 43:307-314.
214. Goodin MG, Bray BJ, Rosen RJ Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse. Food Chem Toxicol 2006, 44:1496-1504.
215. Nadir A, Reddy D, Van Thiel DH Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000, 95:3634-3637.
216. Stevens T, Qadri A, Zein NN Two patients with acute liver injury associated with the use of the herbal weight-loss supplement Hydroxycut. Ann Intern Med 2005, 142:477-478.
217. Jones FJ, Andrews AH Acute injury associated with the herbal supplement Hydroxycut in a soldier deployed in Iraq. Am J Gastroenterol 2007, 102:2357-2358.
218. Dara L, Hewett J, Lim K Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008, 14:6999-7004.
219. Laczek J, Duncan M Three cases of acute hepatitis in patients taking Hydroxycut bodybuilding supplement. Am J Gastroenterol 2008, 103(S1):143.
220. Shim M, Saab S Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009, 54:406-408.
221. Fong T-L, et al. Hepatotoxicity due to Hydroxycut; a case series. Am J Gastroenterol 2010, 105:1561-1566.
222. Schoepfer AM, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007, 47:521-526.
223. Elinav E, et al. Association between Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007, 47:514-520.
224. Duque JM, et al. Hepatotoxicity associated with the consumption of herbal slimming products. Med Clin (Barc) 2007, 128:238-239.
225. Manso G, et al. Spanish reports of hepatotoxicity associated with Herbalife products. J Hepatol 2008, 49:289-290.
226. Woolf GM, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994, 121:729-735.
227. Horowitz RS, et al. The clinical spectrum of jin bu huan toxicity. Arch Intern Med 1996, 156:899-903.
228. Conti E, et al. Lycopodium similiaplex-induced acute hepatitis: a case report. Eur J Gastroenterol Hepatol 2008, 20:468-471.
229. Teschke R, Genthner A, Wolff A Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herb mixtures. J Ethnopharmacol 2009, 123:378-384.
230. Stickel F, et al. Hepatitis induced by kava (Piper methysticum rhizome). J Hepatol 2003, 39:62-67.
231. Centers for Disease Control and Prevention (CDC) Hepatic toxicity possibly associated with kava-containing products-United States, Germany and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep 2002, 51:1065-1067.
232. Teschke R, Schwarzenboeck A, Hennermann K-H Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008, 20:1182-1193.
233. Russmann S, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003, 15:1033-1036.
234. Gow PJ, et al. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003, 178:442-443.
235. Humbertson CL, Akhtar J, Krenzelok EP Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol 2003, 41:109-113.
236. Weise B, et al. Toxic hepatitis after intake of kava-kava. Verdauungskrankheiten 2003, 4:166-169.
237. Fu PP, et al. Toxicity of kava-kava. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008, 26:89-112.
238. Singh YN Potential for interaction of kava and St John's wort and prescription medications. J Ethnopharmacol 2005, 100:108-113.
239. Bressler R Herb-drug interactions: interactions between kava and prescription medications. Geriatrics 2005, 60:24-25.
240. Russmann S, Lauterburg BH, Helbling A Kava hepatotoxicity. Ann Intern Med 2001, 135:68-69.
241. Teschke R, Gaus W, Loew D Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 2003, 10:440-446.
242. Borum ML Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001, 96:1654-1655.
243. Neff GW, et al. Acute hepatitis associated with the use of a Chinese herbal product, ma huang. J Hepatol 2004, 41:1062-1064.
244. Skoulidid F, Alexander G, Davies SE Ma huang associated liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol. 2005, 17:581-584.
245. Estes JD, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003, 138:852-858.
246. Lai SM, Lim KW, Cheng HK Margosa oil poisoning as a cause of toxic encephalopathy. Singapore Med J 1990, 31:463-465.
247. Koga Y, et al. Inhibition of mitochondrial functions by margosa oil: possible implications in the pathogenesis of Reye's syndrome. Pediatr Res 1987, 22:184-187.
248. Sinniah R, et al. Animal model of margosa oil ingestion with Reye-like syndrome. Pathogenesis of microvesicular fatty liver. J Pathol 1989, 159:255-264.
249. Harvey J, Colin-Jones DG Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981, 282:186-187.
250. Wang MY, et al. Morinda citrifolia (noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002, 23:1127-1141.
251. Salomon N Noni juice 1999, Woodland, The tropical fruit with 101 medical uses: Utah, 1-32.
252. Millonig G, Stadlmann S, Vogel W Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 2005, 17:445-447.
253. Stadlbauer V, et al. Hepatotoxicity of noni juice: report of two cases. World J Gastroenterol 2005, 11:4758-4760.
254. Yuce B, et al. Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?. Digestion 2006, 73:167-170.
255. Lopaz-Capero Andrada JM, et al. Hepatotoxicity caused by a Noni (Morinda citrifolia) preparation. Rev Esp Enferm Dig 2007, 99:179-181.
256. Stadlbauer V, et al. Herbal does not mean innocuous: the sixth case of hepatotoxicity associated with Morinda citrifolia (noni). Am J Gastroenterol 2008, 103:2406-2407.
257. West BJ, Jensen JJ, Westendorf J Noni juice is not hepatotoxic. World J Gastroenterol 2006, 12:3616-3619.
258. Anderson IB, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996, 124:726-734.
259. Bakerink JA, et al. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 1996, 98:944-947.
260. Khojasteh-Bakht SC, et al. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Drug Metab Dispos 1999, 27:574-580.
261. Cohen DL, Del Toto Y A case of valerian-associated hepatotoxicity. J Clin Gastroenterol 2008, 42:961-962.
262. Jorge OA, Jorge AD Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm 2005, 97:115-124.
263. Adachi M, et al. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann Intern Med 2003, 139:488-492.
264. Hasegawa R, et al. Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. Cancer Lett 1998, 123:185-191.
265. Nakagawa Y, et al. ATP-generating glycolytic substrates prevent N-nitrosofenfluramine-induced cytotoxicity in isolated rat hepatocytes. Chem Biol Interact 2006, 164:93-101.
266. Ministry of Health, Labor, and Welfare Hepatic injury in cases taking self-imported healthfoods or non-approved drugs [press release]. Ministry of Health, Labor, and Welfare Accessed at. http://www.mhlw.go.jp/houdou/2002/07/bo712-1.html.
267. Kawaguchi T, et al. Severe hepatotoxicity associated with N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol 2004, 19:349-350.
268. Favreau JT, et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 2002, 136:590-595.
269. Durazo FA, et al. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol 2004, 99:950-952.
270. Sanchez W, et al. Severe hepatotoxicity associated with the use of the dietary supplement containing usnic acid. Mayo Clin Proc 2006, 81:541-544.
271. Centers for Disease Control and Prevention (CDC) Unexplained severe illness possibly associated with consumption of Kombucha tea- Iowa, 1995. MMWR Morb Mortal Wkly Rep 1995, 44(48):892-893. 899-900.
272. Han D, et al. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol 2004, 67:439-451.